Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4768 Target Snapshot

Acetylcholinesterase · SINGLE PROTEIN · Bos taurus

681Compounds
117Assays
16Approved Drugs
689.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P23795. Use UniProt P23795 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P23795 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Acetylcholinesterase as ChEMBL target CHEMBL4768, mapped to UniProt P23795. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Acetylcholinesterase
SINGLE PROTEIN · Bos taurus
As of 2026-09-14
ChEMBL target ID
CHEMBL4768
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P23795
Acetylcholinesterase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Acetylcholinesterase is the right protein anchor across sources, using UniProt P23795 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAcetylcholinesterase
UniProt AccessionP23795
Component TypeProtein
Sequence Length613 aa

Acetylcholinesterase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Acetylcholinesterase, mapped to UniProt P23795. Sequence length is 613 aa.

Mapped IDP23795
Review nameAcetylcholinesterase
OrganismBos taurus
Clinical Profile

Clinical Phase Distribution

16
Approved
1
Phase III
4
Phase II
Assay Mix

Activity Type Distribution

IC50616.0
KI73.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL225567 10.7 IC50 0.02 Preclinical
CHEMBL140476 10.61 IC50 0.0245 Preclinical
CHEMBL225198 10.22 IC50 0.06 Preclinical
CHEMBL338755 10.22 Ki 0.06 Preclinical
CHEMBL208599 10.17 IC50 0.0674 Preclinical
CHEMBL3216655 10.05 IC50 0.09 Preclinical
CHEMBL1652 9.92 IC50 0.12 Approved
CHEMBL477141 9.77 IC50 0.17 Preclinical
CHEMBL223443 9.7 IC50 0.2 Preclinical
CHEMBL381499 9.7 IC50 0.2 Preclinical
Distribution

pChEMBL Value Distribution

65
5.0
46
5.5
64
6.0
73
6.5
92
7.0
45
7.5
53
8.0
44
8.5
25
9.0
10
9.5
pChEMBL
Approved Drugs

Approved Drugs

RIVASTIGMINE
CHEMBL636
Approved 1998
DONEPEZIL
CHEMBL502
Approved 1996
DONEPEZIL HYDROCHLORIDE
CHEMBL1678
Approved 1996
TACRINE
CHEMBL95
Approved 1993
TACRINE HYDROCHLORIDE
CHEMBL1677
Approved 1993
AMBENONIUM
CHEMBL1652
Approved 1956
PYRIDOSTIGMINE
CHEMBL1115
Approved 1955
EDROPHONIUM CHLORIDE
CHEMBL1128
Approved 1951
PROCAINAMIDE
CHEMBL640
Approved 1950
Assay Landscape

Assay Landscape

117
Total Assays
489
Tested Compounds
1
Assay Types
Binding — 117 assays, 489 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 81 296 6.6
assay format 19 124 7.2
cell-based format 14 62 7.2
tissue-based format 3 7 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine